Texas · Senate Bill 883 · 89th Legislature, Regular Session

Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.

  1. Introduced Jan 23, 2025
  2. In committee Feb 13, 2025
  3. Passed the Senate Apr 10, 2025
  4. Died  
  5. To the governor  
  6. Became law  

Every action

28 steps, oldest first, as the legislature records them.

Show the 20 earlier steps
  1. SenateReceived by the Secretary of the Senate
  2. SenateFiled
  3. SenateRead first time
  4. SenateReferred to Health & Human Services
  5. SenateCo-author authorized
  6. CommitteeScheduled for public hearing on . . . · Senate Health & Human Services
  7. CommitteeConsidered in public hearing · Senate Health & Human Services
  8. CommitteeTestimony taken in committee · Senate Health & Human Services
  9. CommitteeLeft pending in committee · Senate Health & Human Services
  10. CommitteeConsidered in public hearing · Senate Health & Human Services
  11. CommitteeVote taken in committee · Senate Health & Human Services
  12. CommitteeReported favorably w/o amendments · Senate Health & Human Services
  13. SenateCommittee report printed and distributed
  14. SenatePlaced on intent calendar
  15. SenateCo-author authorized
  16. SenateRules suspended-Regular order of business
  17. SenateRecord vote
  18. SenateRead 2nd time & passed to engrossment
  19. SenateRecord vote
  20. SenateRules suspended-Regular order of business
  1. SenateRecord vote
  2. SenateRead 3rd time
  3. SenatePassed
  4. SenateRecord vote
  5. SenateReported engrossed
  6. HouseReceived from the Senate
  7. HouseRead first time
  8. CommitteeReferred to Public Health · House Public Health

Roll calls

5 recorded votes: 4 on the floor, 1 in committee. Each shows how every member voted.

The bill was read third time and was passed · Full Senate

Passed 23–7
Apr 10, 2025 · journal entry
Yes 23 No 7 Not voting 1
Democrats: 4 yes, 7 no Republicans: 19 yes, 0 no
How each member voted

Yes · 23

No · 7

Excused · 1

SB 883 , Relating to patient access to prescription drugs for off-label use for COVID-19 treatment. — The motion prevailed · Full Senate

Passed 23–7
Apr 10, 2025 · journal entry
Yes 23 No 7 Not voting 1
Democrats: 4 yes, 7 no Republicans: 19 yes, 0 no
How each member voted

Yes · 23

No · 7

Excused · 1

SB 883 , Relating to patient access to prescription drugs for off-label use for COVID-19 treatment. — The motion prevailed · Full Senate

Passed 23–7
Apr 10, 2025 · journal entry
Yes 23 No 7 Not voting 1
Democrats: 4 yes, 7 no Republicans: 19 yes, 0 no
How each member voted

Yes · 23

No · 7

Excused · 1

The bill was read second time and was passed to engrossment · Full Senate

Passed 23–7
Apr 10, 2025 · journal entry
Yes 23 No 7 Not voting 1
Democrats: 4 yes, 7 no Republicans: 19 yes, 0 no
How each member voted

Yes · 23

No · 7

Excused · 1

Committee and other votes

DateWhereQuestionResult
Apr 7, 2025 Senate Health & Human Services Health & Human Services: Reported favorably w/o amendments Passed 8–1

Sponsors

The member who introduced it, joined by 2 cosponsors: 2 Republicans.

All 2 cosponsors

From Texas's official records (ftp.legis.state.tx.us), checked Nov 1, 2026. Text links go to the official versions; LegiList does not copy bill text.